Significant increase in cytotoxic T lymphocytes and natural killer cells by triphala: A clinical phase i study

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Phetkate, Pratya ^a   Kummalue, Tanawan ^b   U Pratya, Yaowalak ^b   Kietinun, Somboon ^a  

^a THAMMASAT UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD16 ANTIGEN; CD56 ANTIGEN; HERBACEOUS AGENT; IMMUNOSTIMULATING AGENT; TRIPHALA; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOLOGICAL PARAMETERS; IMMUNOSTIMULATION; LABORATORY TEST; MALE; NATURAL KILLER CELL; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84871463147     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/239856     Document Type: Article

References (31)

1. UNAIDS,. Global report, UNAIDS report on the global AIDS epidemic/2010, http://www.unaids.org/globalreport/documents/20101123-GlobalReport-full-en
2. May M. T., Inqle S. M., Life expectancy of HIV-positive adults: a review. Sex Health 2011 8 4 526 533
3. Kottilil S., Chun T. W., Moir S., Liu S., McLaughlin M., Hallahan C. W., Maldarelli F., Corey L., Fauci A. S., Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function. Journal of Infectious Diseases 2003 187 7 1038 1045 2-s2.0-0037384061 10.1086/368222 (Pubitemid 36399345)
4. Qi Y., Martin M. P., Gao X., Jacobson L., Goedert J. J., Buchbinder S., Kirk G. D., O'Brien S. J., Trowsdale J., Carrington M., KIR/HLA pleiotropism: protection against both HIV and opportunistic infections. PLoS Pathogens 2006 2 8 e79 2-s2.0-33846236211 10.1371/journal.ppat.0020079 (Pubitemid 44299882)
5. Sonkar RMishra R. N., Immunomodulatory activity of Triphala megaext. International Journal of Research in Pharmaceutical and Biomedical Sciences 2011 2 2 575 578
6. Mukherjee P. K., Rai S., Bhattacharyya S., Debnath P. K., Biswas T. K., Jana U., Pandit S., Saha B. P., Paul P. K., Clinical study of "Triphala"-a well known phytomedicine from India. Iranian Journal of Pharmacology and Therapeutics 2006 5 1 51 54 2-s2.0-36849014070 (Pubitemid 351325776)
7. Sharma A., Sharma K. K., Chemoprotective role of triphala against 1,2-dimethylhydrazine dihydrochloride induced carcinogenic damage to mouse liver. Indian Journal of Clinical Biochemistry 2011 26 3 290 295 2-s2.0-79955787729 10.1007/s12291-011-0138-y
8. Sabina E. P., Rasool M. K., Mathew L., In vivo and in vitro immunomodulatory effects of Indian ayurvedic herbal formulation triphala on experimental induced inflammation. Pharmacologyonline 2009 2 840 849 2-s2.0-70349097257
9. Russell L., Mazzio E., Badisa R., Differential cytotoxicity of Triphala and its phenolic constituent gallic acid on human prostate cancer LNCap and normal cells. Anticancer Research 2011 31 11 3739 3745
10. Shi Y., Sahu R. P., Srivastava S. K., Triphala inhibits both in vitro and in vivo xenograft growth of pancreatic tumor cells by inducing apoptosis. BMC Cancer 2008 8, article 294 2-s2.0-55349122598 10.1186/1471-2407-8-294
11. Sandhya T., Lathika K. M., Pandey B. N., Mishra K. P., Potential of traditional ayurvedic formulation, Triphala, as a novel anticancer drug. Cancer Letters 2006 231 2 206 214 2-s2.0-29844455687 10.1016/j.canlet.2005.01.035 (Pubitemid 43038731)
12. Lu K., Chakroborty D., Sarkar C., Lu T., Xie Z., Liu Z., Basu S., Triphala and its active constituent chebulinic acid are natural inhibitors of vascular endothelial growth factor-a mediated angiogenesis. PLoS ONE 2012 7 8 e43934
13. Srikumar R., Jeya Parthasarathy N., Sheela Devi R., Immunomodulatory activity of triphala on neutrophil functions. Biological and Pharmaceutical Bulletin 2005 28 8 1398 1403 2-s2.0-25644436953 10.1248/bpb.28.1398 (Pubitemid 41379688)
14. The Institute of Thai Traditional Medicine and Ministry of Public Health,. List of Herbal Medicinal Products A.D., 2011, http://www.nlem.in.th/ sites/default/files/herbal-book.pdf
15. Vermeire T., Pieters M., Rennen M., Bos P., Probabilistic assessment factors for human health risk assessment. A practical guide. RIVM Report 2001 601516005. http://rivm.openrepository.com/rivm/bitstream/10029/9560/1/601516005. pdf
16. + T cell function in the course of human immunodeficiency virus infection. Gradual decline of both naive and memory alloreactive T cells. Journal of Clinical Investigation 1994 94 5 1947 1952 2-s2.0-0027948118
17. + T-cells: function and response to HIV infection. Current HIV Research 2004 2 1 23 37 2-s2.0-2342597876 10.2174/1570162043485077 (Pubitemid 38854922)
18. Mavilio D., Benjamin J., Daucher M., Lombardo G., Kottilil S., Planta M. A., Marcenaro E., Bottino C., Moretta L., Moretta A., Fauci A. S., Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proceedings of the National Academy of Sciences of the United States of America 2003 100 25 15011 15016 2-s2.0-10744222779 10.1073/pnas.2336091100 (Pubitemid 37518008)
19. Singh E., Sharma S., Pareek A., Dwivedi J., Yadav S., Sharma S., Phytochemistry, traditional uses and cancer chemopreventive activity of Amla (Phyllanthus emblica): the sustainer. Journal of Applied Pharmaceutical Science 2011 2 1 176 183
20. Huabprasert S., Kasetsinsombat K., Kangsadalampai K., The Phyllanthus emblica L. infusion carries immunostimulatory activity in a mouse model. Journal of The Medical Association of Thailand 2012 95 supplement 2 S75 S82
21. Liu H., Zhang L., Lu S., Evaluation of antioxidant and immunity activities of quercetin in isoproterenol-treated rats. Molecules 2012 17 4 4281 4291
22. Wintergerst E. S., Maggini S., Hornig D. H., Immune-enhancing role of Vitamin C and zinc and effect on clinical conditions. Annals of Nutrition and Metabolism 2006 50 2 85 94 2-s2.0-33644697589 10.1159/000090495 (Pubitemid 43328672)
23. Aher V., Wahi A., Immunomodulatory activity of alcohol extract of Terminalia chebula Retz Combretaceae. Tropical Journal of Pharmaceutical Research 2011 10 5 567 575
24. SuryaPrakash D. V., Sree Satya N., Sumanjali A., Meena V., Pharmacological review on Terminalia chebula. International Journal of Research in Pharmaceutical and Biomedical Sciences 2012 3 2 679 683
25. Saraphanchotiwitthaya A., Sirpalakit P., Ingkaninan K., Effects of Terminalia bellerica Roxb. Methanolic extract on mouse immune response in vitro. Maejo International Journal of Science and Technology 2008 2 2 400 407
26. Chung A. W., Navis M., Isitman G., Centre R., Finlayson R., Bloch M., Gelgor L., Kelleher A., Kent S. J., Stratov I., Activation of NK cells by ADCC responses during early HIV infection. Viral Immunology 2011 24 2 171 175 2-s2.0-79953251062 10.1089/vim.2010.0108
27. Baum L. L., Role of humoral immunity in host defense against HIV. Current HIV/AIDS Reports 2010 7 1 11 18 2-s2.0-77249085588 10.1007/s11904-009-0036-6
28. Isitman G., Stratov I., Kent S., Antibody-dependent cellular cytotoxicity and NK cell-driven immune escape in HIV infection: implications for HIV vaccine development. Advances in Virology 2012 2012 8 637208 10.1155/2012/637208
29. Facciabene A., Motz G., Coukos G., T-regulatory cells: key players in tumor immune escape and angiogenesis. Cancer Research 2012 72 9 2162 2171
30. Moreno-Fernandez M., Rueda C. M., Rusie L., Chougnet C. A., Regulatory T cells control HIV replication in activated T cells through a cAMP-dependent mechanism. Blood 2011 117 20 5372 5380
31. + T cells to the seat of memory. Proceedings of the National Academy of Sciences 2012 109 22 8358 8359